$fdct 2024 Q4 10-K

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	FDCT	Deferred Tax Assets Cumulative Nol DeferredTaxAssetsCumulativeNOL	-1395876	usd
CY2022Q4	FDCT	Deferred Tax Liabilities Cumulative Nol DeferredTaxLiabilitiesCumulativeNOL	-293134	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	158115	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	293134	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	37070	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	100117	usd
CY2023Q4	FDCT	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	49647	usd
CY2022Q4	FDCT	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	34218	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	244832	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	427469	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	48302	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-224144	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-48302	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	224144	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	230010	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1067350	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1395876	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	1395876	usd
CY2023Q4	FDCT	Deferred Tax Assets Pre Tax Income DeferredTaxAssetsPreTaxIncome	230010	usd
CY2023Q4	FDCT	Deferred Tax Assets Net Operating Loss DeferredTaxAssetsNetOperatingLoss	1165866	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1395876	usd
CY2023	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	1395876	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	244832	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001722731
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023Q4	FDCT	Original Issue Discount Promissory Note OriginalIssueDiscountPromissoryNote		usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable		usd
CY2022Q4	us-gaap	Guaranty Assets GuarantyAssets		usd
CY2022Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent		usd
CY2022Q4	FDCT	Fair Value Of Trading Positions For Firm Profit FairValueOfTradingPositionsForFirmProfit		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	FDCT	Business Acquisition Loan BusinessAcquisitionLoan		usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent		usd
CY2022Q4	FDCT	Fair Value Of Trading Positions For Firm Loss Current FairValueOfTradingPositionsForFirmLossCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	FDCT	Adjustments To Additional Paid In Capital Intercompany Guarantee AdjustmentsToAdditionalPaidInCapitalIntercompanyGuarantee		usd
CY2022	FDCT	Subscription Receivable SubscriptionReceivable		usd
CY2022	FDCT	Increase Decrease In Customer Funds IncreaseDecreaseInCustomerFunds		usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities		usd
CY2022	FDCT	Increase Decrease In Related Party Guarantee IncreaseDecreaseInRelatedPartyGuarantee		usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
CY2022	FDCT	Increase Decrease In Accrued Income IncreaseDecreaseInAccruedIncome		usd
CY2022	FDCT	Increase Decrease In Right Of Use Asset Lease IncreaseDecreaseInRightOfUseAssetLease		usd
CY2022	FDCT	Proceeds From Business Acquisition Sellers Note ProceedsFromBusinessAcquisitionSellersNote		usd
CY2022	FDCT	Payments For Proceeds From Changes In Paidin Capital PaymentsForProceedsFromChangesInPaidinCapital		usd
CY2022	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	FDCT	Preferred Stock For Acquisition PreferredStockForAcquisition		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	11579825	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	388584729	shares
CY2023	FDCT	No Insider Trading Flag NoInsiderTradingFlag	true
CY2023	dei	Auditor Firm AuditorFirmId	5968
CY2023	dei	Auditor Name AuditorName	Olayinka Oyebola
CY2023	dei	Auditor Location AuditorLocation	Lagos, Nigeria
CY2023Q4	us-gaap	Cash Cash	31316461	usd
CY2022Q4	us-gaap	Cash Cash	264829	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	175640	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121987	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1029000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65583	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	403191	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	226594	usd
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	8200000	usd
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	200000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	9219	usd
CY2022Q4	FDCT	Original Issue Discount Promissory Note OriginalIssueDiscountPromissoryNote	55000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	40948652	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	821225	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1087543	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	761642	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36062	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36062	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1035619	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1305493	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1293255	usd
CY2023Q4	us-gaap	Guaranty Assets GuarantyAssets	1353170	usd
CY2023Q4	us-gaap	Income Taxes Receivable Noncurrent IncomeTaxesReceivableNoncurrent	177206	usd
CY2023Q4	FDCT	Fair Value Of Trading Positions For Firm Profit FairValueOfTradingPositionsForFirmProfit	1396066	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39683	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	163572	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4034	usd
CY2023Q4	us-gaap	Assets Assets	47543066	usd
CY2022Q4	us-gaap	Assets Assets	2916218	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	179979	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	53229	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	60742	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	47369	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	534500	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	429500	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	550000	usd
CY2023Q4	FDCT	Business Acquisition Loan BusinessAcquisitionLoan	350000	usd
CY2023Q4	FDCT	Cares Act Paycheck Protection Program Advance Current CaresActPaycheckProtectionProgramAdvanceCurrent	20652	usd
CY2022Q4	FDCT	Cares Act Paycheck Protection Program Advance Current CaresActPaycheckProtectionProgramAdvanceCurrent	40139	usd
CY2023Q4	FDCT	Related Party Advances RelatedPartyAdvances	793339	usd
CY2022Q4	FDCT	Related Party Advances RelatedPartyAdvances	5988	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	30220270	usd
CY2023Q4	FDCT	Fair Value Of Trading Positions For Firm Loss Current FairValueOfTradingPositionsForFirmLossCurrent	520808	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36419	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	770984	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	40269	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33487693	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1166494	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	846581	usd
CY2023Q4	FDCT	Cares Act Paycheck Protection Program Advance Noncurrent CaresActPaycheckProtectionProgramAdvanceNoncurrent	122689	usd
CY2022Q4	FDCT	Cares Act Paycheck Protection Program Advance Noncurrent CaresActPaycheckProtectionProgramAdvanceNoncurrent	131194	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3264	usd
CY2023Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	33062	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	14703	usd
CY2023Q4	us-gaap	Liabilities Liabilities	34493289	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1312391	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	388584729	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	388584729	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	211275550	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	211275550	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	38858	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	21127	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15389569	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5725530	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	225228	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17544	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2643647	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4216823	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13010838	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1547778	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	38939	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	56049	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	47543066	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2916218	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6507042	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5434792	usd
CY2023	us-gaap	Gross Profit GrossProfit	6247858	usd
CY2022	us-gaap	Gross Profit GrossProfit	1018939	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2943913	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1623031	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1512790	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	382864	usd
CY2023	us-gaap	Depreciation Depreciation	213910	usd
CY2022	us-gaap	Depreciation Depreciation	3894	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4670613	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2009789	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1577245	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-990850	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	6848	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	72644	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2570	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7615	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9418	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-80259	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1567827	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1071109	usd
CY2023	us-gaap	Profit Loss ProfitLoss	1567827	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1071109	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	329492915	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	158048019	shares
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	207684	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	18250	usd
CY2023	FDCT	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interests OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterests	207684	usd
CY2022	FDCT	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interests OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterests	18250	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1775511	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1052859	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	17972	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	10785	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1757539	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1063644	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1707864	usd
CY2022	FDCT	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne	31250	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	93750	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
CY2022	FDCT	Stock Issued During Period Value New Issues Two StockIssuedDuringPeriodValueNewIssuesTwo	20385	usd
CY2022	FDCT	Stock Issued During Period Value Issued For Financing Cost StockIssuedDuringPeriodValueIssuedForFinancingCost	71521	usd
CY2022	FDCT	Stock Issued During Period Value New Issues Three StockIssuedDuringPeriodValueNewIssuesThree	17800	usd
CY2022	FDCT	Stock Issued During Period Value New Issues Four StockIssuedDuringPeriodValueNewIssuesFour	19750	usd
CY2022	FDCT	Stock Issued During Period Value Issued For Services One StockIssuedDuringPeriodValueIssuedForServicesOne	9475	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	18250	usd
CY2022	FDCT	Stock Issued During Period Value New Issues Five StockIssuedDuringPeriodValueNewIssuesFive	300000	usd
CY2022	FDCT	Stock Issued During Period Value Issued For Services Two StockIssuedDuringPeriodValueIssuedForServicesTwo	60000	usd
CY2022	FDCT	Stock Issued During Period Value Issued For Services Three StockIssuedDuringPeriodValueIssuedForServicesThree	166000	usd
CY2022	FDCT	Stock Issued During Period Value Issued For Services Four StockIssuedDuringPeriodValueIssuedForServicesFour	76000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1069267	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1547778	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1547778	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1547778	usd
CY2023	FDCT	Stock Issued During Period Value Issued For Financing Cost One StockIssuedDuringPeriodValueIssuedForFinancingCostOne	60525	usd
CY2023	FDCT	Stock Issued During Period Value New Issues Six StockIssuedDuringPeriodValueNewIssuesSix	550000	usd
CY2023	FDCT	Stock Issued During Period Value Issued For Services Five StockIssuedDuringPeriodValueIssuedForServicesFive	26000	usd
CY2023	FDCT	Stock Issued During Period Value New Issues Seven StockIssuedDuringPeriodValueNewIssuesSeven	5500000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	90000	usd
CY2023	FDCT	Stock Issued During Period Series A Perferred Values Issued For Cash StockIssuedDuringPeriodSeriesAPerferredValuesIssuedForCash	2500000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2538000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1510906	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	207684	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1573176	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13010838	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13010838	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1573176	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1069267	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	22503	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	159051	usd
CY2023	us-gaap	Depreciation Depreciation	213910	usd
CY2022	us-gaap	Depreciation Depreciation	3894	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	26000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	405225	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21526	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21526	usd
CY2023	FDCT	Subscription Receivable SubscriptionReceivable	8000000	usd
CY2023	FDCT	Acquired Fixed Assets Net AcquiredFixedAssetsNet	373448	usd
CY2022	FDCT	Acquired Fixed Assets Net AcquiredFixedAssetsNet	-417	usd
CY2023	FDCT	Acquired Intangible Assets AcquiredIntangibleAssets	12238	usd
CY2022	FDCT	Acquired Intangible Assets AcquiredIntangibleAssets	7234	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	984943	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	65956	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	176597	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-91841	usd
CY2023	FDCT	Increase Decrease In Original Issue Discount Promissory Note IncreaseDecreaseInOriginalIssueDiscountPromissoryNote	-55000	usd
CY2022	FDCT	Increase Decrease In Original Issue Discount Promissory Note IncreaseDecreaseInOriginalIssueDiscountPromissoryNote	55000	usd
CY2023	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-9219	usd
CY2022	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	-7897	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	126750	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14202	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	730715	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-25717	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	18359	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	5479	usd
CY2023	FDCT	Increase Decrease In Customer Funds IncreaseDecreaseInCustomerFunds	30220270	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-875258	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	39683	usd
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	846581	usd
CY2023	FDCT	Increase Decrease In Related Party Guarantee IncreaseDecreaseInRelatedPartyGuarantee	-1353170	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	177206	usd
CY2023	FDCT	Increase Decrease In Accrued Income IncreaseDecreaseInAccruedIncome	1035619	usd
CY2023	FDCT	Increase Decrease In Right Of Use Asset Lease IncreaseDecreaseInRightOfUseAssetLease	39683	usd
CY2023	FDCT	Increase Decrease In Due To Accrued Expenses Related Party IncreaseDecreaseInDueToAccruedExpensesRelatedParty	105000	usd
CY2022	FDCT	Increase Decrease In Due To Accrued Expenses Related Party IncreaseDecreaseInDueToAccruedExpensesRelatedParty	26000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20980530	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-516046	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	348404	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	269831	usd
CY2023	FDCT	Payments To Acquire Effect Of Exchange Rates PaymentsToAcquireEffectOfExchangeRates	-207684	usd
CY2022	FDCT	Payments To Acquire Effect Of Exchange Rates PaymentsToAcquireEffectOfExchangeRates	-18250	usd
CY2023	FDCT	Proceeds From Business Acquisition Sellers Note ProceedsFromBusinessAcquisitionSellersNote	350000	usd
CY2023	FDCT	Payments For Proceeds From Changes In Paidin Capital PaymentsForProceedsFromChangesInPaidinCapital	1582325	usd
CY2023	us-gaap	Payments For Proceeds From Previous Acquisition PaymentsForProceedsFromPreviousAcquisition	-2538000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1164955	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-251581	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	13373	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	8123	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-550000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	550000	usd
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-19487	usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	-10493	usd
CY2023	FDCT	Proceeds From Sba Loan ProceedsFromSBALoan	-8505	usd
CY2022	FDCT	Proceeds From Sba Loan ProceedsFromSBALoan	-8505	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	787351	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-78565	usd
CY2023	FDCT	Stock Issued For Financing StockIssuedForFinancing	150525	usd
CY2022	FDCT	Stock Issued For Financing StockIssuedForFinancing	71521	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6050000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	414185	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2500000	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-17110	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-8791	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8906147	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	937475	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	31051632	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	169848	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	264829	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94981	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31316461	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	264829	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	150525	usd
CY2023	FDCT	Preferred Stock For Acquisition PreferredStockForAcquisition	2538000	usd
CY2021Q4	us-gaap	Cash Cash	93546	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	20000	usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zBI5qDR6FHn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zegy7obzv5F4">Consolidated Financial Statement Preparation and Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company prepared the consolidated financial statements according to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Estimates include revenue recognition, the allowance for doubtful accounts, website and internal-use software development costs, recoverability of intangible assets with finite lives, and other long-lived assets. Actual results could materially differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31316461	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264829	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	175640	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	121987	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	51653	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	19884	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1512790	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	382864	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zjNWlnELGmNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zuvKCBY27s25">Concentrations of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Cash</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with three months or less of original maturities. The Company maintains its cash balances at a single financial institution. The Company maintains its cash balances at a single financial institution. The balances do not exceed Federal Deposit Insurance Corporation (FDIC) limits as of December 31, 2022. However, as of December 31, 2023, the majority of the cash balances was held with non-FDIC financial institutions in Malta, UK, and other countries. On December 31, 2023, and 2022, the Company had $<span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20231231_zTsqS52Rksn2" title="Cash on hand">31,316,461</span> and $<span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_zhJ53c34QMUb" title="Cash and cash equivalent">264,829</span> cash and cash equivalent held at the financial institution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Revenues</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending December 31, 2023, and 2022, the Company generated $</span><span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231_z7WaITgE5uz">12,754,900</span> and $<span id="xdx_90E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231_zn1rfFFjAW6" title="Revenues">6,453,731</span> in revenues, an increase of over <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zujvHT7ZzSc4"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zrI5zZUKrYnk">101.81</span></span>% from previous year. The revenues mostly comprised of three primary business segments: (1) Technology and Software Development, (2) Wealth Management, and (3) Investment and Margin Brokerage Business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 - Summary of Significant Accounting Policies (continued)</b></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Accounts Receivable</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2023, and 2022, the company’s top three (3) customers comprise roughly <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zsbc0RUrXSMl" title="Concentration risk percentage">98.79</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_z8vSvUJiFphb" title="Concentration risk percentage">82.99</span>% of total A/R, respectively. The loss of any of the top three (3) customers would significantly impact the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Significant Acquisitions</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company completed the Acquisition of <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zGqnkERz2LG3" title="Business acquisition, percentage of voting interests acquired">100.00</span>% of the issued and outstanding shares of Alchemy Prime Limited (“APL”) on November 30, 2023 (“Acquisition Date”) from Alchemy Prime Holdings Ltd. (“Seller” or “APHL”), through an exchange for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1ewE3arF6ke" title="Number of shares acquired">966,379</span> Series B preferred convertible stocks valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXfv3H8hLlb7" title="Number of shares acquired value">1,362,594</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company completed the Acquisition of the remaining <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_zzLQFsolPKJl" title="Business acquisition, percentage of voting interests acquired">49.90</span>% of the issued and outstanding shares of Alchemy Markets Holdings Ltd (Alchemy BVI) and its subsidiary Alchemy Markets Ltd (AML) on November 30, 2023 (“Acquisition Date”), from Alchemy Prime Holdings Ltd., through an exchange for <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zaC9DNpkFNj7" title="Number of shares acquired">833,621</span> Series B preferred convertible stocks valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrezxYZ6B064" title="Number of shares acquired value">1,175,406</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimated the total purchase price for the Acquisition(s) or Transaction(s) to be $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__srt--TitleOfIndividualAxis__custom--GopeSKundnaniMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeHoldingsLtdMember_zqu2I9dVcKw7" title="Number of shares acquired value">2,538,000</span>. The Seller is a UK entity, with Mr. Gope S. Kundnani (“Kundnani”) as the (sole) natural person holding one hundred percent (<span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__srt--TitleOfIndividualAxis__custom--GopeSKundnaniMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeHoldingsLtdMember_zTwVx4MV4BV" title="Business acquisition percentage">100</span>%) shareholding in the APHL. Kundnani is also a controlling shareholder in the Company, a related party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, the Company, Kundnani, and the current management are responsible for making strategic and operational decisions for both APL and AML (“Targets”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As there is no quoted market for Series B Preferred convertible stock, and the Acquisition of <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zM3lTrUc8Qf2" title="Business acquisition, percentage of voting interests acquired">100</span>% of the equity of APL and <span id="xdx_906_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_z1E6zIBVKdWa" title="Business acquisition, percentage of voting interests acquired">49.90</span>% of AML are related party transactions, we valued the exchange of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zii0ixs1hf9a" title="Conversion of shares">1,800,000</span> shares of Series B Preferred convertible stock based on audited net financial assets (book value) of the targets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net financial assets of <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zP8RUWS1mr55" title="Business acquisition, percentage of voting interests acquired">100</span>% APL were $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zUOHbikhOtX1" title="Number of shares acquired value">1,362,594</span>, and <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uPure_c20231130__srt--OwnershipAxis__custom--AlchemyMarketsLtdMember_zH56w6Vvg2r9" title="Ownership pecentage">49.90</span>% of AML was $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zATv3MwplUVd" title="Number of shares acquired value">1,175,406</span>, with a total purchase price of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrkswJ1fFCfh" title="Number of shares acquired value">2,533,334</span> for <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_z7HXPkOcTDk8" title="Number of shares issued">1,800,000</span> shares of Series B Preferred convertible stock or $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20231130_zl5ZXMLC8x4c" title="Shares issue dprice per share">1.41</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table 1. Closing Acquisition Consideration Breakdown</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series B Preferred convertible stock Issued for Purchase of APL and AML</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_ecustom--ScheduleOfBusinessAcquisitionsConsiderationBreakdownTableTextBlock_za22plQ53AZ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B1_z4TtcIBxkmj8" style="display: none">SCHEDULE OF ACQUISITION CONSIDERATION BREAKDOWN</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Financial Assets (Book Value)</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase %</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase Price ($)</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Type of Shares</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price per Shares</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b># of Shares</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Local Currency</b></span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USD ($)</b></span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares of</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APL</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">£<span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_uGBP_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zK4vISd5otd6" title="Net Financial Assets">1,118,035</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_fKDEp_z8snKSAJkry4" title="Net Financial Assets">1,362,594</span> <sup>(1)</sup></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--BusinessAcquisitionPurchasePercentage_pid_dp_uPure_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z9A4wX4IxIce" title="Purchase percentage">100.00%</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zslC7mOsXX7j" title="Purchase Price">1,362,594</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_ztFkWyVXg439" title="Price per Shares">1.41</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zKVyTvsweRq2" title="Shares">966,379</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AML</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">€<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_uGBP_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zwN3q2hWwz13" title="Net Financial Assets"> 2,255,556</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_fKDIp_zluLvqfnboZb" title="Net Financial Assets">2,351,192</span> <sup>(2)</sup></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--BusinessAcquisitionPurchasePercentage_pid_dp_uPure_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z8ANAy5UoCy" title="Purchase percentage">49.90</span>%</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zX5V8VRGHzbl" title="Purchase Price">1,175,406</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zk7hcbbPEZda" title="Price per Shares">1.41</span></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zhVlW7x5mY5a" title="Shares">833,621</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z6MfqR0UOuvf" title="Purchase Price">2,538,000</span></b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zZai0pZXFfuc" title="Shares">1,800,000</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F02_z2mTmYmNonfe" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_z8D0AzqN8uS6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, £1 = $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDUVVJU0lUSU9OIENPTlNJREVSQVRJT04gQlJFQUtET1dOIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndUSDToGBPMember_zlzLofmgY1tk" title="Foreign currency exchange rate, translation">1.2165</span>, Net Financial Assets based on June 30, 2022, audited financial statements</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F00_zGu9bRjBMFri">(2)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zl69bouN4j32" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of November 30, 2022, €1 EUR = $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDUVVJU0lUSU9OIENPTlNJREVSQVRJT04gQlJFQUtET1dOIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231130__us-gaap--AwardTypeAxis__custom--PeriodEndUSDToAUDMember_zJPvV4CYIs6h" title="Foreign currency exchange rate, translation">1.042</span>, Net Financial Assets based on November 30, 2022, audited financial statements</span></td> </tr></table> <p id="xdx_8AE_zWysDi5lWOj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 805-50-15-6, based on the ownership of Kundnani and the management structure post-acquisition, we believe the following guidance in the transactions between entities under common control subsections applies to combinations between entities or businesses under common control:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Seller (APHL or Kundnani) transfers its controlling interest in APL and AML to the Company controlled by the Seller, directly or indirectly through his ownership as an individual or through APHL. This transaction is a legal organization change, but not the reporting entity. The reporting entity remains the Company.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC staff’s conclusions expressed during the deliberations in EITF 02-5 that common control exists between (or among) separate entities in the following situations: An individual or enterprise holds more than 50% of the voting ownership interest of each entity. A group of shareholders has more than 50% of the voting ownership interest of each entity, and contemporary written evidence of an agreement to vote a majority of the entities’ shares in concert exists. Kundnani meets these criteria.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have accounted for the Acquisition under the acquisition method of accounting per ASC 805, with the Company treated as the accounting acquirer and Targets treated as the “acquired” Company for financial reporting purposes. We determine the Company an accounting acquirer based on the following facts: (i) after the Acquisition(s), shareholders of the Company held the majority of the voting interest of the combined Company; (ii) the Board of Directors of the Company possess majority control of the Board of Directors of the combined Company; and (iii) members of the management of the Company are responsible for the management of the combined Company. As such, we have treated the financial statements of the Company as the historical financial statements of the combined Company. The Company will present consolidated or combined financial statements in place of financial statements of individual entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have identified the Company as the legal acquirer, as it is the entity that issued securities. Comparatively, we have identified Targets as the legal acquiree, the entity whose equity interests are acquired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 - Summary of Significant Accounting Policies (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have recognized Targets ‘assets and liabilities as their carrying amounts in the combined financial statements of the controlling party, the Company, immediately before the Acquisition. This approach does not necessitate a fair value adjustment or a recognition of goodwill that would typically follow a standard business combination. Therefore, we have recorded assets and liabilities at book value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction’s equity structure involves the issuance of Series B preferred convertible stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zpqH3FbmeO8d" title="Number of shares acquired value">2,538,000</span> and is reflected in the Company’s equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The post-acquisition consolidation process eliminates any existing intercompany transactions or balances between the Company and Target(s). Although the initial recognition does not adjust assets and liabilities to fair value, the Company evaluates intangible assets in Target’s financial statements on December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AML Purchase Price Allocation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zWpoPj3szaXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AML’s Balance Sheet as of November 30, 2023 (Acquisition Date):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BD_zN9gnE5Hqyy4" style="display: none">SCHEDULE OF PURCHASE PRICE ALLOCATION</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember_zQNbmY5EQi0l" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Description</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Book Value, $</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><b>Assets:</b></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zbbyCWufdQsf" style="vertical-align: bottom; background-color: White"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents <sup id="xdx_F4D_zXXNvdCraFR">(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">3,215,638</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zuLiJ0VBvDXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Prepaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">5,277</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_zBKESwr9tM2h" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial Assets through profit and less <sup id="xdx_F4B_zPwuYi0SnvSj">(2)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,070,795</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRelatedPartyGuarantee_iI_z1IKu7n7TNY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Related party guarantee <sup id="xdx_F44_zJsjLKuVHYK7">(3)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,340,432</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedIncome_iI_zegu34FP5bp6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accrued income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,545,557</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_zbFbPJSDkEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax receivable <span><sup id="xdx_F44_zbB4nxGJPACk">(4)</sup></span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,538</td><td style="text-align: left"></td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalizedSoftwareNet_iI_zfasQc0sNhx7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Capitalized software, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">295,391</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zS2ORGmyLxuk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets <sup id="xdx_F4F_ztn7nz0cJ5Z9">(5)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,391</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zTNy7u74MPo7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify"><b>Total assets:</b></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>7,651,019</b></p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liabilities:</b></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zVEu1KEAZScc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts Payable <sup id="xdx_F4A_zn2eVMBhHxB5">(6)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">173,060</p></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iNI_di_zdrXWyFvCUBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liability at fair value through profit and loss <sup id="xdx_F4F_zpZrIVEBrwNc">(7)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">515,906</td><td style="text-align: left"></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCreditors_iI_zRBiqFqmyOFe" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities - Creditors <sup>(11)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerFunds_iI_zDflnmY2Tyl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer funds<span><sup id="xdx_F4B_zseUkcdFAXb5">(8)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,773,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_zJbV7YjdWkXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities<span><sup id="xdx_F4B_zhXxZbYGnio7">(9)</sup></span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,570</td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zSwlqnOD9vok" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify"><b>Total liabilities</b></td><td style="padding-bottom: 2.5pt"><b> </b></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>3,811,360</b></p></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zhrDdKiutm62" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Net assets, (A)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,839,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedAccumulatedOtherComprehensiveIncomeLoss_iI_zQKALX1jULy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Accumulated other comprehensive income (loss), (B)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">53,605</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsPurchasePriceValue_iI_zTuSojuUx4fe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Purchase Price, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zzHS0YZNBRt" title="Shares">833,621</span> Series B Preferred Shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zLeJn2kclf5g" title="Price per Shares">1.41</span>, (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,175,406</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedPaidInCapital_iI_zcPPVaHWBHii" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Increase in APIC (A) – (B) – (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">2,610,648</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>APL Purchase Price Allocation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">APL’s Balance Sheet as of November 30, 2023 (Acquisition Date):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember_zYMIzcBlnr9g" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Description</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Book Value, $</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><b>Assets:</b></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zchI3uj86ex8" style="vertical-align: bottom; background-color: White"> <td style="width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents, including cash at liquidity provider <sup id="xdx_F41_zLam9PDp1X52">(1)</sup></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">28,562,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zwX0Q5a0Tkc3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets <sup id="xdx_F4B_zyNUPJEhevq7">(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,520</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_ztbBBUcVFDr7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify">Prepaid</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">405,702</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zS0mgsicCwPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify"><b>Total assets:</b></td><td style="padding-bottom: 2.5pt"><b> </b></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>29,125,559</b></p></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><b>Liabilities:</b></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_zdmUMyDvSeH9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred Tax<sup id="xdx_F4D_zCxskD3nSsMh">(9)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">430,142</td><td style="text-align: left"></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCreditors_iI_zsBU4xSbNqth" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current liabilities - Creditors <sup id="xdx_F43_zIARygCAQ7U7">(10)</sup></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">874,636</td><td style="text-align: left"></td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerFunds_iI_zlBvooP01H7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer funds <span><sup id="xdx_F4A_zHSXbI0y8UQd">(8)</sup></span></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,239,126</td><td style="text-align: left"></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRelatedPartyAdvances_iNI_di_zuFo8L1UKfQf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party advances</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,500,619</td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zT2FImTqiGh5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Total liabilities</b></p></td><td style="padding-bottom: 2.5pt"><b> </b></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><b>$</b></td><td style="border-bottom: Black 2.5pt double; text-align: right"><b>30,044,523</b></td><td style="padding-bottom: 2.5pt; text-align: left"><b> </b></td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zVskEOUV7wTl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Net assets (A)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(918,964</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedAccumulatedOtherComprehensiveIncomeLoss_iI_zW72H149Awq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify">Accumulated other comprehensive income (loss), (B)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(5,539</p></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsPurchasePriceValue_iI_z9WefsAODpB4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Purchase Price, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zuujGO6kG8K2" title="Shares issued">966,379</span> Series B Preferred Shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zg6345mixyp2" title="Price per share">1.41</span>, (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1,362,594</p></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedPaidInCapital_iI_z9wPQ54duVA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify">Increase in APIC (A) – (B) – (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,276,019</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0E_zxtORoO2Vmc9">(1)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_zT5j0aATH25k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize cash and cash equivalents held by AML and APL and deposits in bank accounts and liquidity providers that can be accessed on demand or within 90 days.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F08_zTBSoPwEB0h3">(2)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1D_zpYJQPw2gWg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial assets at fair values for AML through profit and loss are derivative contracts in favor of AML. They are included in our other current assets in the consolidated balance sheet as of November 30, 2023. We determine financial assets at fair values by reference to market prices or rates quoted at the end of the reporting period. Observable market prices or rates support the valuation techniques since their variables include only data from observable markets. We categorize AML’s derivative financial instruments as level 2.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup> </sup></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span><b>Note 2 - Summary of Significant Accounting Policies (continued)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup> </sup></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F04_zDHnHEJessC">(3)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zfvPcVsrNZwc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantee provided by Alchemy BVI as a parent to AML for any shortfall in the net capital.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0C_zREUpdSNNndl">(4)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_zdX1yAVbFuR2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated overpaid tax to Commissioner Tax Revenue, Malta.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F01_z60sQydgDjS5">(5)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zVOMxa4J6pp6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All property and equipment are initially recorded at historical cost and included in our fixed assets, net in the consolidated balance sheet as of November 30, 2023. Historical cost includes expenditures directly attributable to the Acquisition of the items. We calculate depreciation using the straight-line method to allocate their cost or revalued amounts to their residual values over their estimated useful lives.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0A_zYEJb9hJVWzb">(6)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F12_zeNbWHdrSls5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables comprise obligations to pay for goods or services acquired from suppliers in the ordinary course of business. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F02_z6b4XcgD8Sg5">(7)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1D_zN5GqRyJvr11" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at fair values for AML through profit and loss are derivative contracts against AML. They are included in our other current assets in the consolidated balance sheet as of November 30, 2023. We determine financial liabilities at fair values by reference to market prices or rates quoted at the end of the reporting period. Observable market prices or rates support the valuation techniques since their variables include only data from observable markets. We categorize AML’s derivative financial instruments as level 2.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F09_zhXki1G2pcoh">(8)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_zt8E1c1bua8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer net trading deposits funds placed with the Company by clients intended to trade FX, securities, or other investment activities.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F0E_z5KUOTktOlg2">(9)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1D_zSa78aFbblx5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize deferred tax using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial statements. We include deferred tax liabilities in our consolidated balance sheet as of November 30, 2023. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill; deferred tax is not accounted for if it stems from the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred tax is determined using tax rates (and Malta laws) that have been enacted or substantially enacted by the end of the reporting period and are expected to apply when the related deferred tax asset is realized, or the deferred tax liability is settled.</span></td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F06_ztABPn5CgDgd">(10)</sup></span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_zn2jvZFHln9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term borrowings are primarily composed of lines of credit and short-term loans from financial institutions.</span></td> </tr></table> <p id="xdx_8A8_zJ0j0hc1toae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31316461	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	264829	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12754900	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6453731	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.41
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1800	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2023	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	22503	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	159051	usd
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	97996	usd
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	97996	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	329492915	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	329492915	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	158048019	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	158048019	shares
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zcI2ItSeuBn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z34iVJwXhuZa">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these classifications impacted reported operating or net loss for any presented period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q1	us-gaap	Finite Lived Intangible Assets Fair Value Disclosure FiniteLivedIntangibleAssetsFairValueDisclosure	2644842	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2643647	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4216823	usd
CY2023Q4	FDCT	Working Capital Deficit WorkingCapitalDeficit	11260603	usd
CY2022Q4	FDCT	Working Capital Deficit WorkingCapitalDeficit	345269	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1573176	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1069267	usd
CY2023Q4	us-gaap	Cash Cash	31316461	usd
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2022Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1851758	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1586989	usd
CY2023Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	1052059	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	825347	usd
CY2023Q4	FDCT	Unamortized Capitalized Software Cost UnamortizedCapitalizedSoftwareCost	799699	usd
CY2022Q4	FDCT	Unamortized Capitalized Software Cost UnamortizedCapitalizedSoftwareCost	761642	usd
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000	shares
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	20000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	60742	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	47369	usd
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1000000	usd
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	256908	usd
CY2019Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1000000	usd
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	196908	usd
CY2023Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	100000	usd
	us-gaap	Payments For Rent PaymentsForRent	1000	usd
	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	6300	usd
CY2020Q1	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	From February 2020, this agreement continues every year upon written request by the Company. The Company uses the office for sales and marketing in Europe and Asia.
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P11M
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	500	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39683	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	36419	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3264	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	42390	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	33062	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	14703	usd
CY2021Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	260000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	96778105	shares
CY2022Q1	FDCT	Common Stock Issued Outstanding Percentage CommonStockIssuedOutstandingPercentage	0.6462	pure
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	388584729	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	388584729	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	211275550	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	211275550	shares
CY2017Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1000000	shares
CY2017Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	50000	usd
CY2019Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2967000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	30000000	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	115000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	550000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	20000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-706	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	18250	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	17544	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	207684	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	225228	usd
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The Act reduces the corporate federal tax rate from a maximum of 35% to a 21% rate for corporations. The rate reduction will take effect on January 1, 2018. Therefore, we have applied the tax rate of 21% to the ending balance of federal deferred tax assets.
CY2023Q4	FDCT	Deferred Tax Assets Income Loss Per Books M One Difference DeferredTaxAssetsIncomeLossPerBooksMOneDifference	230010	usd
CY2023Q4	FDCT	Deferred Tax Liabilities Income Loss Per Books M One Difference DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference	48302	usd
CY2022Q4	FDCT	Deferred Tax Assets Income Loss Per Books M One Difference DeferredTaxAssetsIncomeLossPerBooksMOneDifference	-1067350	usd
CY2022Q4	FDCT	Deferred Tax Liabilities Income Loss Per Books M One Difference DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference	-224144	usd
CY2023Q4	FDCT	Deferred Tax Assets Stock Options Issued For Services DeferredTaxAssetsStockOptionsIssuedForServices	176525	usd
CY2023Q4	FDCT	Deferred Tax Liabilities Stock Options Issued For Services DeferredTaxLiabilitiesStockOptionsIssuedForServices	37070	usd
CY2022Q4	FDCT	Deferred Tax Assets Stock Options Issued For Services DeferredTaxAssetsStockOptionsIssuedForServices	476746	usd
CY2022Q4	FDCT	Deferred Tax Liabilities Stock Options Issued For Services DeferredTaxLiabilitiesStockOptionsIssuedForServices	100117	usd
CY2023Q4	FDCT	Deferred Tax Asset Depreciation And Amortization DeferredTaxAssetDepreciationAndAmortization	236413	usd
CY2023Q4	FDCT	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	49647	usd
CY2022Q4	FDCT	Deferred Tax Asset Depreciation And Amortization DeferredTaxAssetDepreciationAndAmortization	162945	usd
CY2022Q4	FDCT	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	34218	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	642948	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	135019	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	427659	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	89808	usd
CY2023Q4	FDCT	Deferred Tax Assets Prior Year Nol DeferredTaxAssetsPriorYearNOL	-1395876	usd
CY2023Q4	FDCT	Deferred Tax Liabilities Prior Year Nol DeferredTaxLiabilitiesPriorYearNOL	-293134	usd
CY2022Q4	FDCT	Deferred Tax Assets Prior Year Nol DeferredTaxAssetsPriorYearNOL	-968217	usd
CY2022Q4	FDCT	Deferred Tax Liabilities Prior Year Nol DeferredTaxLiabilitiesPriorYearNOL	-203325	usd
CY2023Q4	FDCT	Deferred Tax Assets Cumulative Nol DeferredTaxAssetsCumulativeNOL	-752928	usd
CY2023Q4	FDCT	Deferred Tax Liabilities Cumulative Nol DeferredTaxLiabilitiesCumulativeNOL	-158115	usd

CY2022Q4

FDCT

Deferred Tax Assets Cumulative Nol

DeferredTaxAssetsCumulativeNOL

-1395876

usd

CY2022Q4

FDCT

Deferred Tax Liabilities Cumulative Nol

DeferredTaxLiabilitiesCumulativeNOL

-293134

usd

CY2023Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

158115

usd

CY2022Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

293134

usd

CY2023Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

37070

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

100117

usd

CY2023Q4

FDCT

Deferred Tax Assets Depreciation And Amortization

DeferredTaxAssetsDepreciationAndAmortization

49647

usd

CY2022Q4

FDCT

Deferred Tax Assets Depreciation And Amortization

DeferredTaxAssetsDepreciationAndAmortization

34218

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

244832

usd

CY2022Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

427469

usd

CY2023

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2022

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.21

pure

CY2023

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

48302

usd

CY2022

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

-224144

usd

CY2023

us-gaap

Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance

IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

-48302

usd

CY2022

us-gaap

Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance

IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

224144

usd

CY2023Q4

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

230010

usd

CY2022Q4

us-gaap

Operating Loss Carryforwards

OperatingLossCarryforwards

1067350

usd

CY2023Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

1395876

usd

CY2023Q4

us-gaap

Operating Loss Carryforwards Valuation Allowance

OperatingLossCarryforwardsValuationAllowance

1395876

usd

CY2023Q4

FDCT

Deferred Tax Assets Pre Tax Income

DeferredTaxAssetsPreTaxIncome

230010

usd

CY2023Q4

FDCT

Deferred Tax Assets Net Operating Loss

DeferredTaxAssetsNetOperatingLoss

1165866

usd

CY2023

us-gaap

Valuation Allowance Deferred Tax Asset Change In Amount

ValuationAllowanceDeferredTaxAssetChangeInAmount

1395876

usd

CY2023

us-gaap

Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense

DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense

1395876

usd

CY2023Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

244832

usd

CY2023

dei

Entity Central Index Key

EntityCentralIndexKey

0001722731

CY2023Q4

us-gaap

Notes And Loans Receivable Net Current

NotesAndLoansReceivableNetCurrent

usd

CY2023Q4

FDCT

Original Issue Discount Promissory Note

OriginalIssueDiscountPromissoryNote

usd

CY2022Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

usd

CY2022Q4

us-gaap

Guaranty Assets

GuarantyAssets

usd

CY2022Q4

us-gaap

Income Taxes Receivable Noncurrent

IncomeTaxesReceivableNoncurrent

usd

CY2022Q4

FDCT

Fair Value Of Trading Positions For Firm Profit

FairValueOfTradingPositionsForFirmProfit

usd

CY2022Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

usd

CY2023Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

usd

CY2022Q4

FDCT

Business Acquisition Loan

BusinessAcquisitionLoan

usd

CY2022Q4

us-gaap

Customer Refund Liability Current

CustomerRefundLiabilityCurrent

usd

CY2022Q4

FDCT

Fair Value Of Trading Positions For Firm Loss Current

FairValueOfTradingPositionsForFirmLossCurrent

usd

CY2022Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

usd

CY2022Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

usd

CY2022Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

usd

CY2023Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2022Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

usd

CY2023

FDCT

Adjustments To Additional Paid In Capital Intercompany Guarantee

AdjustmentsToAdditionalPaidInCapitalIntercompanyGuarantee

usd

CY2022

FDCT

Subscription Receivable

SubscriptionReceivable

usd

CY2022

FDCT

Increase Decrease In Customer Funds

IncreaseDecreaseInCustomerFunds

usd

CY2022

us-gaap

Increase Decrease In Derivative Liabilities

IncreaseDecreaseInDerivativeLiabilities

usd

CY2022

us-gaap

Increase Decrease In Operating Lease Liability

IncreaseDecreaseInOperatingLeaseLiability

usd

CY2022

us-gaap

Increase Decrease In Deferred Liabilities

IncreaseDecreaseInDeferredLiabilities

usd

CY2022

FDCT

Increase Decrease In Related Party Guarantee

IncreaseDecreaseInRelatedPartyGuarantee

usd

CY2022

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

usd

CY2022

FDCT

Increase Decrease In Accrued Income

IncreaseDecreaseInAccruedIncome

usd

CY2022

FDCT

Increase Decrease In Right Of Use Asset Lease

IncreaseDecreaseInRightOfUseAssetLease

usd

CY2022

FDCT

Proceeds From Business Acquisition Sellers Note

ProceedsFromBusinessAcquisitionSellersNote

usd

CY2022

FDCT

Payments For Proceeds From Changes In Paidin Capital

PaymentsForProceedsFromChangesInPaidinCapital

usd

CY2022

us-gaap

Payments For Proceeds From Previous Acquisition

PaymentsForProceedsFromPreviousAcquisition

usd

CY2022

us-gaap

Proceeds From Issuance Of Preferred Stock And Preference Stock

ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

usd

CY2023

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

usd

CY2022

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

usd

CY2023

us-gaap

Interest Paid Net

InterestPaidNet

usd

CY2022

us-gaap

Interest Paid Net

InterestPaidNet

usd

CY2022

us-gaap

Stock Issued1

StockIssued1

usd

CY2022

FDCT

Preferred Stock For Acquisition

PreferredStockForAcquisition

usd

CY2023Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

usd

CY2022Q4

us-gaap

Deferred Tax Assets Liabilities Net

DeferredTaxAssetsLiabilitiesNet

usd

CY2023

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

usd

CY2022

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

usd

CY2023

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

usd

CY2022

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

usd

CY2023

dei

Document Type

DocumentType

10-K

CY2023

dei

Document Annual Report

DocumentAnnualReport

true

CY2023

dei

Document Period End Date

DocumentPeriodEndDate

2023-12-31

CY2023

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2023

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

No

CY2023

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2023

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2023

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2023

dei

Entity Filer Category

EntityFilerCategory

Non-accelerated Filer

CY2023

dei

Entity Small Business

EntitySmallBusiness

true

CY2023

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

true

CY2023

dei

Entity Ex Transition Period

EntityExTransitionPeriod

false

CY2023

dei

Document Fin Stmt Error Correction Flag

DocumentFinStmtErrorCorrectionFlag

false

CY2023

dei

Entity Shell Company

EntityShellCompany

false

CY2023Q4

dei

Entity Public Float

EntityPublicFloat

11579825

usd

CY2024Q4

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

388584729

shares

CY2023

FDCT

No Insider Trading Flag

NoInsiderTradingFlag

true

CY2023

dei

Auditor Firm

AuditorFirmId

5968

CY2023

dei

Auditor Name

AuditorName

Olayinka Oyebola

CY2023

dei

Auditor Location

AuditorLocation

Lagos, Nigeria

CY2023Q4

us-gaap

Cash

31316461

usd

CY2022Q4

us-gaap

Cash

264829

usd

CY2023Q4

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

175640

usd

CY2022Q4

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

121987

usd

CY2023Q4

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

1029000

usd

CY2022Q4

us-gaap

Accounts Receivable Net Current

AccountsReceivableNetCurrent

65583

usd

CY2023Q4

us-gaap

Prepaid Expense Current

PrepaidExpenseCurrent

403191

usd

CY2022Q4

us-gaap

Prepaid Expense Current

PrepaidExpenseCurrent

226594

usd

CY2023Q4

us-gaap

Common Stock Share Subscribed But Unissued Subscriptions Receivable

CommonStockShareSubscribedButUnissuedSubscriptionsReceivable

8200000

usd

CY2022Q4

us-gaap

Common Stock Share Subscribed But Unissued Subscriptions Receivable

CommonStockShareSubscribedButUnissuedSubscriptionsReceivable

200000

usd

CY2022Q4

us-gaap

Notes And Loans Receivable Net Current

NotesAndLoansReceivableNetCurrent

9219

usd

CY2022Q4

FDCT

Original Issue Discount Promissory Note

OriginalIssueDiscountPromissoryNote

55000

usd

CY2023Q4

us-gaap

Assets Current

AssetsCurrent

40948652

usd

CY2022Q4

us-gaap

Assets Current

AssetsCurrent

821225

usd

CY2023Q4

us-gaap

Capitalized Computer Software Net

CapitalizedComputerSoftwareNet

1087543

usd

CY2022Q4

us-gaap

Capitalized Computer Software Net

CapitalizedComputerSoftwareNet

761642

usd

CY2023Q4

us-gaap

Investments In Affiliates Subsidiaries Associates And Joint Ventures

InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

36062

usd

CY2022Q4

us-gaap

Investments In Affiliates Subsidiaries Associates And Joint Ventures

InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

36062

usd

CY2023Q4

us-gaap

Accrued Investment Income Receivable

AccruedInvestmentIncomeReceivable

1035619

usd

CY2023Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

1305493

usd

CY2022Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

1293255

usd

CY2023Q4

us-gaap

Guaranty Assets

GuarantyAssets

1353170

usd

CY2023Q4

us-gaap

Income Taxes Receivable Noncurrent

IncomeTaxesReceivableNoncurrent

177206

usd

CY2023Q4

FDCT

Fair Value Of Trading Positions For Firm Profit

FairValueOfTradingPositionsForFirmProfit

1396066

usd

CY2023Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

39683

usd

CY2023Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

163572

usd

CY2022Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

4034

usd

CY2023Q4

us-gaap

Assets

47543066

usd

CY2022Q4

us-gaap

Assets

2916218

usd

CY2023Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

179979

usd

CY2022Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

53229

usd

CY2023Q4

us-gaap

Lines Of Credit Current

LinesOfCreditCurrent

60742

usd

CY2022Q4

us-gaap

Lines Of Credit Current

LinesOfCreditCurrent

47369

usd

CY2023Q4

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

534500

usd

CY2022Q4

us-gaap

Accrued Liabilities Current

AccruedLiabilitiesCurrent

429500

usd

CY2022Q4

us-gaap

Notes Payable Current

NotesPayableCurrent

550000

usd

CY2023Q4

FDCT

Business Acquisition Loan

BusinessAcquisitionLoan

350000

usd

CY2023Q4

FDCT

Cares Act Paycheck Protection Program Advance Current

CaresActPaycheckProtectionProgramAdvanceCurrent

20652

usd

CY2022Q4

FDCT

Cares Act Paycheck Protection Program Advance Current

CaresActPaycheckProtectionProgramAdvanceCurrent

40139

usd

CY2023Q4

FDCT

Related Party Advances

RelatedPartyAdvances

793339

usd

CY2022Q4

FDCT

Related Party Advances

RelatedPartyAdvances

5988

usd

CY2023Q4

us-gaap

Customer Refund Liability Current

CustomerRefundLiabilityCurrent

30220270

usd

CY2023Q4

FDCT

Fair Value Of Trading Positions For Firm Loss Current

FairValueOfTradingPositionsForFirmLossCurrent

520808

usd

CY2023Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

36419

usd

CY2023Q4

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

770984

usd

CY2022Q4

us-gaap

Other Liabilities Current

OtherLiabilitiesCurrent

40269

usd

CY2023Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

33487693

usd

CY2022Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

1166494

usd

CY2023Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

846581

usd

CY2023Q4

FDCT

Cares Act Paycheck Protection Program Advance Noncurrent

CaresActPaycheckProtectionProgramAdvanceNoncurrent

122689

usd

CY2022Q4

FDCT

Cares Act Paycheck Protection Program Advance Noncurrent

CaresActPaycheckProtectionProgramAdvanceNoncurrent

131194

usd

CY2023Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

3264

usd

CY2023Q4

us-gaap

Deposit Liabilities Accrued Interest

DepositLiabilitiesAccruedInterest

33062

usd

CY2022Q4

us-gaap

Deposit Liabilities Accrued Interest

DepositLiabilitiesAccruedInterest

14703

usd

CY2023Q4

us-gaap

Liabilities

34493289

usd

CY2022Q4

us-gaap

Liabilities

1312391

usd

CY2023Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2022Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2023Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

388584729

shares

CY2023Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

388584729

shares

CY2022Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

211275550

shares

CY2022Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

211275550

shares

CY2023Q4

us-gaap

Common Stock Value

CommonStockValue

38858

usd

CY2022Q4

us-gaap

Common Stock Value

CommonStockValue

21127

usd

CY2023Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

15389569

usd

CY2022Q4

us-gaap

Additional Paid In Capital

AdditionalPaidInCapital

5725530

usd

CY2023Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

225228

usd

CY2022Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

17544

usd

CY2023Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-2643647

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-4216823

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

13010838

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1547778

usd

CY2023Q4

us-gaap

Minority Interest

MinorityInterest

38939

usd

CY2022Q4

us-gaap

Minority Interest

MinorityInterest

56049

usd

CY2023Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

47543066

usd

CY2022Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

2916218

usd

CY2023

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

6507042

usd

CY2022

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

5434792

usd

CY2023

us-gaap

Gross Profit

GrossProfit

6247858

usd

CY2022

us-gaap

Gross Profit

GrossProfit

1018939

usd

CY2023

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

2943913

usd

CY2022

us-gaap

General And Administrative Expense

GeneralAndAdministrativeExpense

1623031

usd

CY2023

us-gaap

Selling And Marketing Expense

SellingAndMarketingExpense

1512790

usd

CY2022

us-gaap

Selling And Marketing Expense

SellingAndMarketingExpense

382864

usd

CY2023

us-gaap

Depreciation

213910

usd

CY2022

us-gaap

Depreciation

3894

usd

CY2023

us-gaap

Operating Expenses

OperatingExpenses

4670613

usd

CY2022

us-gaap

Operating Expenses

OperatingExpenses

2009789

usd

CY2023

us-gaap

Operating Income Loss

OperatingIncomeLoss

1577245

usd

CY2022

us-gaap

Operating Income Loss

OperatingIncomeLoss

-990850

usd

CY2023

us-gaap

Interest Expense Other

InterestExpenseOther

6848

usd

CY2022

us-gaap

Interest Expense Other

InterestExpenseOther

72644

usd

CY2023

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-2570

usd

CY2022

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-7615

usd

CY2023

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-9418

usd

CY2022

us-gaap

Nonoperating Income Expense

NonoperatingIncomeExpense

-80259

usd

CY2023

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

1567827

usd

CY2022

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

-1071109

usd

CY2023

us-gaap

Profit Loss

ProfitLoss

1567827

usd

CY2022

us-gaap

Profit Loss

ProfitLoss

-1071109

usd

CY2023

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

0.00

CY2022

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

-0.01

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

329492915

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

158048019

shares

CY2023

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

207684

usd

CY2022

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

18250

usd

CY2023

FDCT

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interests

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterests

207684

usd

CY2022

FDCT

Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interests

OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterests

18250

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

1775511

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

-1052859

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

17972

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

10785

usd

CY2023

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1757539

usd

CY2022

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

-1063644

usd

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

1707864

usd

CY2022

FDCT

Stock Issued During Period Value New Issues One

StockIssuedDuringPeriodValueNewIssuesOne

31250

usd

CY2022

us-gaap

Stock Issued During Period Value Issued For Services

StockIssuedDuringPeriodValueIssuedForServices

93750

usd

CY2022

us-gaap

Stock Issued During Period Value New Issues

StockIssuedDuringPeriodValueNewIssues

25000

usd

CY2022

FDCT

Stock Issued During Period Value New Issues Two

StockIssuedDuringPeriodValueNewIssuesTwo

20385

usd

CY2022

FDCT

Stock Issued During Period Value Issued For Financing Cost

StockIssuedDuringPeriodValueIssuedForFinancingCost

71521

usd

CY2022

FDCT

Stock Issued During Period Value New Issues Three

StockIssuedDuringPeriodValueNewIssuesThree

17800

usd

CY2022

FDCT

Stock Issued During Period Value New Issues Four

StockIssuedDuringPeriodValueNewIssuesFour

19750

usd

CY2022

FDCT

Stock Issued During Period Value Issued For Services One

StockIssuedDuringPeriodValueIssuedForServicesOne

9475

usd

CY2022

us-gaap

Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax

OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax

18250

usd

CY2022

FDCT

Stock Issued During Period Value New Issues Five

StockIssuedDuringPeriodValueNewIssuesFive

300000

usd

CY2022

FDCT

Stock Issued During Period Value Issued For Services Two

StockIssuedDuringPeriodValueIssuedForServicesTwo

60000

usd

CY2022

FDCT

Stock Issued During Period Value Issued For Services Three

StockIssuedDuringPeriodValueIssuedForServicesThree

166000

usd

CY2022

FDCT

Stock Issued During Period Value Issued For Services Four

StockIssuedDuringPeriodValueIssuedForServicesFour

76000

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

-1069267

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1547778

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1547778

usd

CY2022Q4

us-gaap

Stockholders Equity

StockholdersEquity

1547778

usd

CY2023

FDCT

Stock Issued During Period Value Issued For Financing Cost One

StockIssuedDuringPeriodValueIssuedForFinancingCostOne

60525

usd

CY2023

FDCT

Stock Issued During Period Value New Issues Six

StockIssuedDuringPeriodValueNewIssuesSix

550000

usd

CY2023

FDCT

Stock Issued During Period Value Issued For Services Five

StockIssuedDuringPeriodValueIssuedForServicesFive

26000

usd

CY2023

FDCT

Stock Issued During Period Value New Issues Seven

StockIssuedDuringPeriodValueNewIssuesSeven

5500000

usd

CY2023

us-gaap

Stock Issued During Period Value Other

StockIssuedDuringPeriodValueOther

90000

usd

CY2023

FDCT

Stock Issued During Period Series A Perferred Values Issued For Cash

StockIssuedDuringPeriodSeriesAPerferredValuesIssuedForCash

2500000

usd

CY2023

us-gaap

Stock Issued During Period Value Acquisitions

StockIssuedDuringPeriodValueAcquisitions

2538000

usd

CY2023

us-gaap

Adjustments To Additional Paid In Capital Other

AdjustmentsToAdditionalPaidInCapitalOther

1510906

usd

CY2023

us-gaap

Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax

OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax

207684

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

1573176

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

13010838

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

13010838

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

1573176

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

-1069267

usd

CY2023

us-gaap

Adjustment For Amortization

AdjustmentForAmortization

22503

usd

CY2022

us-gaap

Adjustment For Amortization

AdjustmentForAmortization

159051

usd

CY2023

us-gaap

Depreciation

213910

usd

CY2022

us-gaap

Depreciation

3894

usd

CY2023

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

26000

usd

CY2022

us-gaap

Issuance Of Stock And Warrants For Services Or Claims

IssuanceOfStockAndWarrantsForServicesOrClaims

405225

usd

CY2023

us-gaap

Provision For Doubtful Accounts

ProvisionForDoubtfulAccounts

21526

usd

CY2022

us-gaap

Provision For Doubtful Accounts

ProvisionForDoubtfulAccounts

21526

usd

CY2023

FDCT

Subscription Receivable

SubscriptionReceivable

8000000

usd

CY2023

FDCT

Acquired Fixed Assets Net

AcquiredFixedAssetsNet

373448

usd

CY2022

FDCT

Acquired Fixed Assets Net

AcquiredFixedAssetsNet

-417

usd

CY2023

FDCT

Acquired Intangible Assets

AcquiredIntangibleAssets

12238

usd

CY2022

FDCT

Acquired Intangible Assets

AcquiredIntangibleAssets

7234

usd

CY2023

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

984943

usd

CY2022

us-gaap

Increase Decrease In Accounts Receivable

IncreaseDecreaseInAccountsReceivable

65956

usd

CY2023

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

176597

usd

CY2022

us-gaap

Increase Decrease In Prepaid Expense

IncreaseDecreaseInPrepaidExpense

-91841

usd

CY2023

FDCT

Increase Decrease In Original Issue Discount Promissory Note

IncreaseDecreaseInOriginalIssueDiscountPromissoryNote

-55000

usd

CY2022

FDCT

Increase Decrease In Original Issue Discount Promissory Note

IncreaseDecreaseInOriginalIssueDiscountPromissoryNote

55000

usd

CY2023

us-gaap

Increase Decrease In Notes Receivable Current

IncreaseDecreaseInNotesReceivableCurrent

-9219

usd

CY2022

us-gaap

Increase Decrease In Notes Receivable Current

IncreaseDecreaseInNotesReceivableCurrent

-7897

usd

CY2023

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

126750

usd

CY2022

us-gaap

Increase Decrease In Accounts Payable

IncreaseDecreaseInAccountsPayable

-14202

usd

CY2023

us-gaap

Increase Decrease In Other Current Liabilities

IncreaseDecreaseInOtherCurrentLiabilities

730715

usd

CY2022

us-gaap

Increase Decrease In Other Current Liabilities

IncreaseDecreaseInOtherCurrentLiabilities

-25717

usd

CY2023

us-gaap

Increase Decrease In Interest Payable Net

IncreaseDecreaseInInterestPayableNet

18359

usd

CY2022

us-gaap

Increase Decrease In Interest Payable Net

IncreaseDecreaseInInterestPayableNet

5479

usd

CY2023

FDCT

Increase Decrease In Customer Funds

IncreaseDecreaseInCustomerFunds

30220270

usd

CY2023

us-gaap

Increase Decrease In Derivative Liabilities

IncreaseDecreaseInDerivativeLiabilities

-875258

usd

CY2023

us-gaap

Increase Decrease In Operating Lease Liability

IncreaseDecreaseInOperatingLeaseLiability

39683

usd

CY2023

us-gaap

Increase Decrease In Deferred Liabilities

IncreaseDecreaseInDeferredLiabilities

846581

usd

CY2023

FDCT

Increase Decrease In Related Party Guarantee

IncreaseDecreaseInRelatedPartyGuarantee

-1353170

usd

CY2023

us-gaap

Increase Decrease In Income Taxes Receivable

IncreaseDecreaseInIncomeTaxesReceivable

177206

usd

CY2023

FDCT

Increase Decrease In Accrued Income

IncreaseDecreaseInAccruedIncome

1035619

usd

CY2023

FDCT

Increase Decrease In Right Of Use Asset Lease

IncreaseDecreaseInRightOfUseAssetLease

39683

usd

CY2023

FDCT

Increase Decrease In Due To Accrued Expenses Related Party

IncreaseDecreaseInDueToAccruedExpensesRelatedParty

105000

usd

CY2022

FDCT

Increase Decrease In Due To Accrued Expenses Related Party

IncreaseDecreaseInDueToAccruedExpensesRelatedParty

26000

usd

CY2023

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

20980530

usd

CY2022

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

-516046

usd

CY2023

us-gaap

Payments To Develop Software

PaymentsToDevelopSoftware

348404

usd

CY2022

us-gaap

Payments To Develop Software

PaymentsToDevelopSoftware

269831

usd

CY2023

FDCT

Payments To Acquire Effect Of Exchange Rates

PaymentsToAcquireEffectOfExchangeRates

-207684

usd

CY2022

FDCT

Payments To Acquire Effect Of Exchange Rates

PaymentsToAcquireEffectOfExchangeRates

-18250

usd

CY2023

FDCT

Proceeds From Business Acquisition Sellers Note

ProceedsFromBusinessAcquisitionSellersNote

350000

usd

CY2023

FDCT

Payments For Proceeds From Changes In Paidin Capital

PaymentsForProceedsFromChangesInPaidinCapital

1582325

usd

CY2023

us-gaap

Payments For Proceeds From Previous Acquisition

PaymentsForProceedsFromPreviousAcquisition

-2538000

usd

CY2023

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

1164955

usd

CY2022

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-251581

usd

CY2023

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

13373

usd

CY2022

us-gaap

Proceeds From Repayments Of Lines Of Credit

ProceedsFromRepaymentsOfLinesOfCredit

8123

usd

CY2023

us-gaap

Proceeds From Repayments Of Notes Payable

ProceedsFromRepaymentsOfNotesPayable

-550000

usd

CY2022

us-gaap

Proceeds From Repayments Of Notes Payable

ProceedsFromRepaymentsOfNotesPayable

550000

usd

CY2023

us-gaap

Proceeds From Other Short Term Debt

ProceedsFromOtherShortTermDebt

-19487

usd

CY2022

us-gaap

Proceeds From Other Short Term Debt

ProceedsFromOtherShortTermDebt

-10493

usd

CY2023

FDCT

Proceeds From Sba Loan

ProceedsFromSBALoan

-8505

usd

CY2022

FDCT

Proceeds From Sba Loan

ProceedsFromSBALoan

-8505

usd

CY2023

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

787351

usd

CY2022

us-gaap

Proceeds From Repayments Of Related Party Debt

ProceedsFromRepaymentsOfRelatedPartyDebt

-78565

usd

CY2023

FDCT

Stock Issued For Financing

StockIssuedForFinancing

150525

usd

CY2022

FDCT

Stock Issued For Financing

StockIssuedForFinancing

71521

usd

CY2023

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

6050000

usd

CY2022

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

414185

usd

CY2023

us-gaap

Proceeds From Issuance Of Preferred Stock And Preference Stock

ProceedsFromIssuanceOfPreferredStockAndPreferenceStock

2500000

usd

CY2023

us-gaap

Proceeds From Payments To Minority Shareholders

ProceedsFromPaymentsToMinorityShareholders

-17110

usd

CY2022

us-gaap

Proceeds From Payments To Minority Shareholders

ProceedsFromPaymentsToMinorityShareholders

-8791

usd

CY2023

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

8906147

usd

CY2022

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

937475

usd

CY2023

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

31051632

usd

CY2022

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

169848

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

264829

usd

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

94981

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

31316461

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

264829

usd

CY2023

us-gaap

Stock Issued1

StockIssued1

150525

usd

CY2023

FDCT

Preferred Stock For Acquisition

PreferredStockForAcquisition

2538000

usd

CY2021Q4

us-gaap

Cash

93546

usd

CY2023Q1

us-gaap

Stock Issued During Period Shares Restricted Stock Award Gross

StockIssuedDuringPeriodSharesRestrictedStockAwardGross

2000000

shares

CY2023Q1

us-gaap

Stock Issued During Period Value Restricted Stock Award Gross

StockIssuedDuringPeriodValueRestrictedStockAwardGross

20000

usd

CY2021Q3

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2023

us-gaap

Use Of Estimates

UseOfEstimates

Consolidated Financial Statement Preparation and Use of Estimates The Company prepared the consolidated financial statements according to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Estimates include revenue recognition, the allowance for doubtful accounts, website and internal-use software development costs, recoverability of intangible assets with finite lives, and other long-lived assets. Actual results could materially differ from these estimates.

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

31316461

usd

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

264829

usd

CY2023Q4

us-gaap

Allowance For Doubtful Accounts Receivable

AllowanceForDoubtfulAccountsReceivable

175640

usd

CY2022Q4

us-gaap

Allowance For Doubtful Accounts Receivable

AllowanceForDoubtfulAccountsReceivable

121987

usd

CY2023

us-gaap

Interest And Debt Expense

InterestAndDebtExpense

51653

usd

CY2022

us-gaap

Interest And Debt Expense

InterestAndDebtExpense

19884

usd

CY2023

us-gaap

Marketing And Advertising Expense

MarketingAndAdvertisingExpense

1512790

usd

CY2022

us-gaap

Marketing And Advertising Expense

MarketingAndAdvertisingExpense

382864

usd

CY2023

us-gaap

Concentration Risk Credit Risk

ConcentrationRiskCreditRisk

Concentrations of Credit Risk Cash Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with three months or less of original maturities. The Company maintains its cash balances at a single financial institution. The Company maintains its cash balances at a single financial institution. The balances do not exceed Federal Deposit Insurance Corporation (FDIC) limits as of December 31, 2022. However, as of December 31, 2023, the majority of the cash balances was held with non-FDIC financial institutions in Malta, UK, and other countries. On December 31, 2023, and 2022, the Company had $31,316,461 and $264,829 cash and cash equivalent held at the financial institution. Revenues For the fiscal year ending December 31, 2023, and 2022, the Company generated $12,754,900 and $6,453,731 in revenues, an increase of over <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zujvHT7ZzSc4"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zrI5zZUKrYnk">101.81% from previous year. The revenues mostly comprised of three primary business segments: (1) Technology and Software Development, (2) Wealth Management, and (3) Investment and Margin Brokerage Business. Note 2 - Summary of Significant Accounting Policies (continued) Accounts Receivable At December 31, 2023, and 2022, the company’s top three (3) customers comprise roughly <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_zsbc0RUrXSMl" title="Concentration risk percentage">98.79% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TopThreeCustomersMember_z8vSvUJiFphb" title="Concentration risk percentage">82.99% of total A/R, respectively. The loss of any of the top three (3) customers would significantly impact the Company’s operations. Significant Acquisitions The Company completed the Acquisition of <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zGqnkERz2LG3" title="Business acquisition, percentage of voting interests acquired">100.00% of the issued and outstanding shares of Alchemy Prime Limited (“APL”) on November 30, 2023 (“Acquisition Date”) from Alchemy Prime Holdings Ltd. (“Seller” or “APHL”), through an exchange for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z1ewE3arF6ke" title="Number of shares acquired">966,379 Series B preferred convertible stocks valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXfv3H8hLlb7" title="Number of shares acquired value">1,362,594. The Company completed the Acquisition of the remaining <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_zzLQFsolPKJl" title="Business acquisition, percentage of voting interests acquired">49.90% of the issued and outstanding shares of Alchemy Markets Holdings Ltd (Alchemy BVI) and its subsidiary Alchemy Markets Ltd (AML) on November 30, 2023 (“Acquisition Date”), from Alchemy Prime Holdings Ltd., through an exchange for <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zaC9DNpkFNj7" title="Number of shares acquired">833,621 Series B preferred convertible stocks valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrezxYZ6B064" title="Number of shares acquired value">1,175,406. The Company estimated the total purchase price for the Acquisition(s) or Transaction(s) to be $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__srt--TitleOfIndividualAxis__custom--GopeSKundnaniMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeHoldingsLtdMember_zqu2I9dVcKw7" title="Number of shares acquired value">2,538,000. The Seller is a UK entity, with Mr. Gope S. Kundnani (“Kundnani”) as the (sole) natural person holding one hundred percent (<span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__srt--TitleOfIndividualAxis__custom--GopeSKundnaniMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeHoldingsLtdMember_zTwVx4MV4BV" title="Business acquisition percentage">100%) shareholding in the APHL. Kundnani is also a controlling shareholder in the Company, a related party. Further, the Company, Kundnani, and the current management are responsible for making strategic and operational decisions for both APL and AML (“Targets”). As there is no quoted market for Series B Preferred convertible stock, and the Acquisition of <span id="xdx_901_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zM3lTrUc8Qf2" title="Business acquisition, percentage of voting interests acquired">100% of the equity of APL and <span id="xdx_906_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_z1E6zIBVKdWa" title="Business acquisition, percentage of voting interests acquired">49.90% of AML are related party transactions, we valued the exchange of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zii0ixs1hf9a" title="Conversion of shares">1,800,000 shares of Series B Preferred convertible stock based on audited net financial assets (book value) of the targets. The net financial assets of <span id="xdx_90D_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember_zP8RUWS1mr55" title="Business acquisition, percentage of voting interests acquired">100% APL were $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zUOHbikhOtX1" title="Number of shares acquired value">1,362,594, and 49.90% of AML was $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zATv3MwplUVd" title="Number of shares acquired value">1,175,406, with a total purchase price of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zrkswJ1fFCfh" title="Number of shares acquired value">2,533,334 for <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember_z7HXPkOcTDk8" title="Number of shares issued">1,800,000 shares of Series B Preferred convertible stock or $1.41 per share. Table 1. Closing Acquisition Consideration Breakdown Series B Preferred convertible stock Issued for Purchase of APL and AML SCHEDULE OF ACQUISITION CONSIDERATION BREAKDOWN <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net Financial Assets (Book Value)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">Purchase %</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">Purchase Price ($)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">Type of Shares</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">Price per Shares</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"># of Shares</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 12%"> </td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">Local Currency</td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center">USD ($)</td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 10%; text-align: center"> </td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"> </td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"> </td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 9%; text-align: center"> </td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 12%; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Shares of</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">APL</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">£<span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_uGBP_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zK4vISd5otd6" title="Net Financial Assets">1,118,035</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_902_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_fKDEp_z8snKSAJkry4" title="Net Financial Assets">1,362,594 (1)</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--BusinessAcquisitionPurchasePercentage_pid_dp_uPure_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z9A4wX4IxIce" title="Purchase percentage">100.00%</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zslC7mOsXX7j" title="Purchase Price">1,362,594</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Series B</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_ztFkWyVXg439" title="Price per Shares">1.41</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyPrimeLimitedMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zKVyTvsweRq2" title="Shares">966,379</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">AML</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">€<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_uGBP_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zwN3q2hWwz13" title="Net Financial Assets"> 2,255,556</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_fKDIp_zluLvqfnboZb" title="Net Financial Assets">2,351,192 (2)</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_903_ecustom--BusinessAcquisitionPurchasePercentage_pid_dp_uPure_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z8ANAy5UoCy" title="Purchase percentage">49.90%</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zX5V8VRGHzbl" title="Purchase Price">1,175,406</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Series B</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zk7hcbbPEZda" title="Price per Shares">1.41</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--AlchemyMarketsLtdMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zhVlW7x5mY5a" title="Shares">833,621</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Total</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">$<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z6MfqR0UOuvf" title="Purchase Price">2,538,000</td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">1,800,000</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td id="xdx_F02_z2mTmYmNonfe" style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"></td><td style="text-align: justify">As of June 30, 2022, £1 = $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDUVVJU0lUSU9OIENPTlNJREVSQVRJT04gQlJFQUtET1dOIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20220630__us-gaap--AwardTypeAxis__custom--PeriodEndUSDToGBPMember_zlzLofmgY1tk" title="Foreign currency exchange rate, translation">1.2165, Net Financial Assets based on June 30, 2022, audited financial statements</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"></td><td style="text-align: justify">As of November 30, 2022, €1 EUR = $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEFDUVVJU0lUSU9OIENPTlNJREVSQVRJT04gQlJFQUtET1dOIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_c20231130__us-gaap--AwardTypeAxis__custom--PeriodEndUSDToAUDMember_zJPvV4CYIs6h" title="Foreign currency exchange rate, translation">1.042, Net Financial Assets based on November 30, 2022, audited financial statements</td> </tr></table> Under ASC 805-50-15-6, based on the ownership of Kundnani and the management structure post-acquisition, we believe the following guidance in the transactions between entities under common control subsections applies to combinations between entities or businesses under common control: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">a)</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Seller (APHL or Kundnani) transfers its controlling interest in APL and AML to the Company controlled by the Seller, directly or indirectly through his ownership as an individual or through APHL. This transaction is a legal organization change, but not the reporting entity. The reporting entity remains the Company.</td></tr></table> The SEC staff’s conclusions expressed during the deliberations in EITF 02-5 that common control exists between (or among) separate entities in the following situations: An individual or enterprise holds more than 50% of the voting ownership interest of each entity. A group of shareholders has more than 50% of the voting ownership interest of each entity, and contemporary written evidence of an agreement to vote a majority of the entities’ shares in concert exists. Kundnani meets these criteria. We have accounted for the Acquisition under the acquisition method of accounting per ASC 805, with the Company treated as the accounting acquirer and Targets treated as the “acquired” Company for financial reporting purposes. We determine the Company an accounting acquirer based on the following facts: (i) after the Acquisition(s), shareholders of the Company held the majority of the voting interest of the combined Company; (ii) the Board of Directors of the Company possess majority control of the Board of Directors of the combined Company; and (iii) members of the management of the Company are responsible for the management of the combined Company. As such, we have treated the financial statements of the Company as the historical financial statements of the combined Company. The Company will present consolidated or combined financial statements in place of financial statements of individual entities. We have identified the Company as the legal acquirer, as it is the entity that issued securities. Comparatively, we have identified Targets as the legal acquiree, the entity whose equity interests are acquired. Note 2 - Summary of Significant Accounting Policies (continued) We have recognized Targets ‘assets and liabilities as their carrying amounts in the combined financial statements of the controlling party, the Company, immediately before the Acquisition. This approach does not necessitate a fair value adjustment or a recognition of goodwill that would typically follow a standard business combination. Therefore, we have recorded assets and liabilities at book value. The transaction’s equity structure involves the issuance of Series B preferred convertible stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20231130__20231130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zpqH3FbmeO8d" title="Number of shares acquired value">2,538,000 and is reflected in the Company’s equity. The post-acquisition consolidation process eliminates any existing intercompany transactions or balances between the Company and Target(s). Although the initial recognition does not adjust assets and liabilities to fair value, the Company evaluates intangible assets in Target’s financial statements on December 31, 2023. AML Purchase Price Allocation AML’s Balance Sheet as of November 30, 2023 (Acquisition Date): SCHEDULE OF PURCHASE PRICE ALLOCATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember_zQNbmY5EQi0l" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Description</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Book Value, $</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zbbyCWufdQsf" style="vertical-align: bottom; background-color: White"> <td style="width: 78%; text-align: justify">Cash and cash equivalents (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">3,215,638</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_zuLiJ0VBvDXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Prepaid</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,277</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets_iI_zBKESwr9tM2h" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Financial Assets through profit and less (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,070,795</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRelatedPartyGuarantee_iI_z1IKu7n7TNY1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Related party guarantee (3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,340,432</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedIncome_iI_zegu34FP5bp6" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accrued income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,545,557</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_zbFbPJSDkEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Tax receivable (4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,538</td><td style="text-align: left"></td></tr> <tr id="xdx_40C_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalizedSoftwareNet_iI_zfasQc0sNhx7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Capitalized software, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">295,391</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zS2ORGmyLxuk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify">Fixed assets (5)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,391</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zTNy7u74MPo7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Total assets:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,651,019</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zVEu1KEAZScc" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accounts Payable (6)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">173,060</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iNI_di_zdrXWyFvCUBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Financial liability at fair value through profit and loss (7)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">515,906</td><td style="text-align: left"></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCreditors_iI_zRBiqFqmyOFe" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current liabilities - Creditors (11)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerFunds_iI_zDflnmY2Tyl2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer funds(8)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,773,824</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iI_zJbV7YjdWkXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: justify">Deferred tax liabilities(9)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">348,570</td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zSwlqnOD9vok" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,811,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zhrDdKiutm62" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Net assets, (A)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,839,660</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedAccumulatedOtherComprehensiveIncomeLoss_iI_zQKALX1jULy5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Accumulated other comprehensive income (loss), (B)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">53,605</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsPurchasePriceValue_iI_zTuSojuUx4fe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Purchase Price, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zzHS0YZNBRt" title="Shares">833,621 Series B Preferred Shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20231130__us-gaap--BusinessAcquisitionAxis__custom--AMLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zLeJn2kclf5g" title="Price per Shares">1.41, (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,175,406</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedPaidInCapital_iI_zcPPVaHWBHii" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Increase in APIC (A) – (B) – (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,610,648</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> APL Purchase Price Allocation APL’s Balance Sheet as of November 30, 2023 (Acquisition Date): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember_zYMIzcBlnr9g" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: justify">Description</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Book Value, $</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_zchI3uj86ex8" style="vertical-align: bottom; background-color: White"> <td style="width: 78%; text-align: justify">Cash and cash equivalents, including cash at liquidity provider (1)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right">28,562,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zwX0Q5a0Tkc3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Fixed assets (2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">157,520</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_ztbBBUcVFDr7" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: justify">Prepaid</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">405,702</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_zS0mgsicCwPi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify">Total assets:</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,125,559</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_iI_zdmUMyDvSeH9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Deferred Tax(9)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">430,142</td><td style="text-align: left"></td></tr> <tr id="xdx_408_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesCreditors_iI_zsBU4xSbNqth" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current liabilities - Creditors (10)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">874,636</td><td style="text-align: left"></td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerFunds_iI_zlBvooP01H7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer funds (8)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,239,126</td><td style="text-align: left"></td></tr> <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRelatedPartyAdvances_iNI_di_zuFo8L1UKfQf" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Related party advances</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,500,619</td><td style="padding-bottom: 1.5pt; text-align: left"></td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_zT2FImTqiGh5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Total liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,044,523</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_zVskEOUV7wTl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Net assets (A)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(918,964</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedAccumulatedOtherComprehensiveIncomeLoss_iI_zW72H149Awq7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify">Accumulated other comprehensive income (loss), (B)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,539</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsPurchasePriceValue_iI_z9WefsAODpB4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: justify">Purchase Price, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231130__20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zuujGO6kG8K2" title="Shares issued">966,379 Series B Preferred Shares valued at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFBVUkNIQVNFIFBSSUNFIEFMTE9DQVRJT04gKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_c20231130__us-gaap--BusinessAcquisitionAxis__custom--APLMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_zg6345mixyp2" title="Price per share">1.41, (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,362,594</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAccumulatedPaidInCapital_iI_z9wPQ54duVA3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: justify">Increase in APIC (A) – (B) – (C)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,276,019</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"></td><td style="text-align: justify">We recognize cash and cash equivalents held by AML and APL and deposits in bank accounts and liquidity providers that can be accessed on demand or within 90 days.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"></td><td style="text-align: justify">Financial assets at fair values for AML through profit and loss are derivative contracts in favor of AML. They are included in our other current assets in the consolidated balance sheet as of November 30, 2023. We determine financial assets at fair values by reference to market prices or rates quoted at the end of the reporting period. Observable market prices or rates support the valuation techniques since their variables include only data from observable markets. We categorize AML’s derivative financial instruments as level 2.</td> </tr></table> Note 2 - Summary of Significant Accounting Policies (continued) <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(3)</td><td style="width: 5pt"></td><td style="text-align: justify">Guarantee provided by Alchemy BVI as a parent to AML for any shortfall in the net capital.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(4)</td><td style="width: 5pt"></td><td style="text-align: justify">Estimated overpaid tax to Commissioner Tax Revenue, Malta.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(5)</td><td style="width: 5pt"></td><td style="text-align: justify">All property and equipment are initially recorded at historical cost and included in our fixed assets, net in the consolidated balance sheet as of November 30, 2023. Historical cost includes expenditures directly attributable to the Acquisition of the items. We calculate depreciation using the straight-line method to allocate their cost or revalued amounts to their residual values over their estimated useful lives.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(6)</td><td style="width: 5pt"></td><td style="text-align: justify">Trade and other payables comprise obligations to pay for goods or services acquired from suppliers in the ordinary course of business. Accounts payable are classified as current liabilities if payment is due within one year or less (or in the normal operating cycle of the business if longer). If not, they are presented as non-current liabilities.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(7)</td><td style="width: 5pt"></td><td style="text-align: justify">Financial liabilities at fair values for AML through profit and loss are derivative contracts against AML. They are included in our other current assets in the consolidated balance sheet as of November 30, 2023. We determine financial liabilities at fair values by reference to market prices or rates quoted at the end of the reporting period. Observable market prices or rates support the valuation techniques since their variables include only data from observable markets. We categorize AML’s derivative financial instruments as level 2.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(8)</td><td style="width: 5pt"></td><td style="text-align: justify">Customer net trading deposits funds placed with the Company by clients intended to trade FX, securities, or other investment activities.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td></td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(9)</td><td style="width: 5pt"></td><td style="text-align: justify">We recognize deferred tax using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts in the financial statements. We include deferred tax liabilities in our consolidated balance sheet as of November 30, 2023. However, deferred tax liabilities are not recognized if they arise from the initial recognition of goodwill; deferred tax is not accounted for if it stems from the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred tax is determined using tax rates (and Malta laws) that have been enacted or substantially enacted by the end of the reporting period and are expected to apply when the related deferred tax asset is realized, or the deferred tax liability is settled.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: right"> </td><td> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(10)</td><td style="width: 5pt"></td><td style="text-align: justify">Short-term borrowings are primarily composed of lines of credit and short-term loans from financial institutions.</td> </tr></table>

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

31316461

usd

CY2022Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

264829

usd

CY2023

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

12754900

usd

CY2022

us-gaap

Revenue From Contract With Customer Excluding Assessed Tax

RevenueFromContractWithCustomerExcludingAssessedTax

6453731

usd

CY2023Q4

us-gaap

Shares Issued Price Per Share

SharesIssuedPricePerShare

1.41

CY2023

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

0

usd

CY2022

us-gaap

Research And Development Expense

ResearchAndDevelopmentExpense

1800

usd

CY2023

us-gaap

Impairment Of Long Lived Assets Held For Use

ImpairmentOfLongLivedAssetsHeldForUse

0

usd

CY2022

us-gaap

Impairment Of Long Lived Assets Held For Use

ImpairmentOfLongLivedAssetsHeldForUse

0

usd

CY2023Q4

us-gaap

Finite Lived Intangible Asset Useful Life

FiniteLivedIntangibleAssetUsefulLife

P3Y

CY2023

us-gaap

Cost Of Goods And Services Sold Amortization

CostOfGoodsAndServicesSoldAmortization

22503

usd

CY2022

us-gaap

Cost Of Goods And Services Sold Amortization

CostOfGoodsAndServicesSoldAmortization

159051

usd

CY2017

us-gaap

Amortization Of Debt Discount Premium

AmortizationOfDebtDiscountPremium

97996

usd

CY2017Q4

us-gaap

Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding

SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding

97996

usd

CY2023

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

329492915

shares

CY2023

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

329492915

shares

CY2022

us-gaap

Weighted Average Number Of Shares Outstanding Basic

WeightedAverageNumberOfSharesOutstandingBasic

158048019

shares

CY2022

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

158048019

shares

CY2023

us-gaap

Prior Period Reclassification Adjustment Description

PriorPeriodReclassificationAdjustmentDescription

Reclassifications Certain prior period amounts were reclassified to conform to the current year’s presentation. None of these classifications impacted reported operating or net loss for any presented period.

CY2020Q1

us-gaap

Finite Lived Intangible Assets Fair Value Disclosure

FiniteLivedIntangibleAssetsFairValueDisclosure

2644842

usd

CY2023Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-2643647

usd

CY2022Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

-4216823

usd

CY2023Q4

FDCT

Working Capital Deficit

WorkingCapitalDeficit

11260603

usd

CY2022Q4

FDCT

Working Capital Deficit

WorkingCapitalDeficit

345269

usd

CY2023

us-gaap

Net Income Loss

NetIncomeLoss

1573176

usd

CY2022

us-gaap

Net Income Loss

NetIncomeLoss

-1069267

usd

CY2023Q4

us-gaap

Cash

31316461

usd

CY2023Q4

us-gaap

Finite Lived Intangible Asset Useful Life

FiniteLivedIntangibleAssetUsefulLife

P3Y

CY2022Q4

us-gaap

Finite Lived Intangible Asset Useful Life

FiniteLivedIntangibleAssetUsefulLife

P3Y

CY2023Q4

us-gaap

Capitalized Computer Software Gross

CapitalizedComputerSoftwareGross

1851758

usd

CY2022Q4

us-gaap

Capitalized Computer Software Gross

CapitalizedComputerSoftwareGross

1586989

usd

CY2023Q4

us-gaap

Capitalized Computer Software Accumulated Amortization

CapitalizedComputerSoftwareAccumulatedAmortization

1052059

usd

CY2022Q4

us-gaap

Capitalized Computer Software Accumulated Amortization

CapitalizedComputerSoftwareAccumulatedAmortization

825347

usd

CY2023Q4

FDCT

Unamortized Capitalized Software Cost

UnamortizedCapitalizedSoftwareCost

799699

usd

CY2022Q4

FDCT

Unamortized Capitalized Software Cost

UnamortizedCapitalizedSoftwareCost

761642

usd

CY2023Q3

us-gaap

Preferred Stock Shares Issued

PreferredStockSharesIssued

4000000

shares

CY2023Q3

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

4000000

shares

CY2023

us-gaap

Related Party Transaction Amounts Of Transaction

RelatedPartyTransactionAmountsOfTransaction

20000

usd

CY2023Q4

us-gaap

Line Of Credit

LineOfCredit

60742

usd

CY2022Q4

us-gaap

Line Of Credit

LineOfCredit

47369

usd

CY2020Q4

us-gaap

Convertible Notes Payable Current

ConvertibleNotesPayableCurrent

1000000

usd

CY2020Q4

us-gaap

Interest Payable Current

InterestPayableCurrent

256908

usd

CY2019Q4

us-gaap

Convertible Notes Payable Current

ConvertibleNotesPayableCurrent

1000000

usd

CY2019Q4

us-gaap

Interest Payable Current

InterestPayableCurrent

196908

usd

CY2023Q4

us-gaap

Repayments Of Debt

RepaymentsOfDebt

100000

usd

us-gaap

Payments For Rent

PaymentsForRent

1000

usd

us-gaap

Proceeds From Lease Payments

ProceedsFromLeasePayments

6300

usd

CY2020Q1

us-gaap

Lessee Operating Lease Description

LesseeOperatingLeaseDescription

From February 2020, this agreement continues every year upon written request by the Company. The Company uses the office for sales and marketing in Europe and Asia.

CY2022Q3

us-gaap

Lessee Operating Lease Term Of Contract

LesseeOperatingLeaseTermOfContract

P11M

CY2022Q3

us-gaap

Payments For Rent

PaymentsForRent

500

usd

CY2023Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

39683

usd

CY2023Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

36419

usd

CY2023Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

3264

usd

CY2023

us-gaap

Operating Lease Expense

OperatingLeaseExpense

42390

usd

CY2023Q4

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.1000

pure

CY2023Q4

us-gaap

Interest Payable Current And Noncurrent

InterestPayableCurrentAndNoncurrent

33062

usd

CY2022Q4

us-gaap

Interest Payable Current And Noncurrent

InterestPayableCurrentAndNoncurrent

14703

usd

CY2021Q1

us-gaap

Capital Units Authorized

CapitalUnitsAuthorized

260000000

shares

CY2021Q1

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

250000000

shares

CY2021Q1

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2021Q1

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

10000000

shares

CY2021Q1

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2022Q1

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2022Q1

us-gaap

Stock Issued During Period Shares New Issues

StockIssuedDuringPeriodSharesNewIssues

96778105

shares

CY2022Q1

FDCT

Common Stock Issued Outstanding Percentage

CommonStockIssuedOutstandingPercentage

0.6462

pure

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2023Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

10000000

shares

CY2022Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

10000000

shares

CY2023Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2022Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2022Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

500000000

shares

CY2023Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2022Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.0001

CY2023Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

388584729

shares

CY2023Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

388584729

shares

CY2022Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

211275550

shares

CY2022Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

211275550

shares

CY2017Q1

us-gaap

Stock Issued During Period Shares Restricted Stock Award Gross

StockIssuedDuringPeriodSharesRestrictedStockAwardGross

1000000

shares

CY2017Q1

us-gaap

Stock Issued During Period Value Restricted Stock Award Gross

StockIssuedDuringPeriodValueRestrictedStockAwardGross

50000

usd

CY2019Q1

us-gaap

Stock Issued During Period Shares New Issues

StockIssuedDuringPeriodSharesNewIssues

2967000

shares

CY2022Q3

us-gaap

Stock Issued During Period Shares Restricted Stock Award Gross

StockIssuedDuringPeriodSharesRestrictedStockAwardGross

30000000

shares

CY2022Q3

us-gaap

Stock Issued During Period Value Restricted Stock Award Gross

StockIssuedDuringPeriodValueRestrictedStockAwardGross

300000

usd

CY2023Q1

us-gaap

Stock Issued During Period Shares Restricted Stock Award Gross

StockIssuedDuringPeriodSharesRestrictedStockAwardGross

115000000

shares

CY2023Q1

us-gaap

Stock Issued During Period Value Restricted Stock Award Gross

StockIssuedDuringPeriodValueRestrictedStockAwardGross

550000

usd

CY2023Q1

us-gaap

Stock Issued During Period Shares Restricted Stock Award Gross

StockIssuedDuringPeriodSharesRestrictedStockAwardGross

2000000

shares

CY2023Q1

us-gaap

Stock Issued During Period Value Restricted Stock Award Gross

StockIssuedDuringPeriodValueRestrictedStockAwardGross

20000

usd

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax

AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

-706

usd

CY2022

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent

18250

usd

CY2022Q4

us-gaap

Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax

AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

17544

usd

CY2023

us-gaap

Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent

OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent

207684

usd

CY2023Q4

us-gaap

Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax

AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

225228

usd

CY2023

us-gaap

Income Tax Examination Description

IncomeTaxExaminationDescription

The Act reduces the corporate federal tax rate from a maximum of 35% to a 21% rate for corporations. The rate reduction will take effect on January 1, 2018. Therefore, we have applied the tax rate of 21% to the ending balance of federal deferred tax assets.

CY2023Q4

FDCT

Deferred Tax Assets Income Loss Per Books M One Difference

DeferredTaxAssetsIncomeLossPerBooksMOneDifference

230010

usd

CY2023Q4

FDCT

Deferred Tax Liabilities Income Loss Per Books M One Difference

DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference

48302

usd

CY2022Q4

FDCT

Deferred Tax Assets Income Loss Per Books M One Difference

DeferredTaxAssetsIncomeLossPerBooksMOneDifference

-1067350

usd

CY2022Q4

FDCT

Deferred Tax Liabilities Income Loss Per Books M One Difference

DeferredTaxLiabilitiesIncomeLossPerBooksMOneDifference

-224144

usd

CY2023Q4

FDCT

Deferred Tax Assets Stock Options Issued For Services

DeferredTaxAssetsStockOptionsIssuedForServices

176525

usd

CY2023Q4

FDCT

Deferred Tax Liabilities Stock Options Issued For Services

DeferredTaxLiabilitiesStockOptionsIssuedForServices

37070

usd

CY2022Q4

FDCT

Deferred Tax Assets Stock Options Issued For Services

DeferredTaxAssetsStockOptionsIssuedForServices

476746

usd

CY2022Q4

FDCT

Deferred Tax Liabilities Stock Options Issued For Services

DeferredTaxLiabilitiesStockOptionsIssuedForServices

100117

usd

CY2023Q4

FDCT

Deferred Tax Asset Depreciation And Amortization

DeferredTaxAssetDepreciationAndAmortization

236413

usd

CY2023Q4

FDCT

Deferred Tax Liabilities Depreciation And Amortization

DeferredTaxLiabilitiesDepreciationAndAmortization

49647

usd

CY2022Q4

FDCT

Deferred Tax Asset Depreciation And Amortization

DeferredTaxAssetDepreciationAndAmortization

162945

usd

CY2022Q4

FDCT

Deferred Tax Liabilities Depreciation And Amortization

DeferredTaxLiabilitiesDepreciationAndAmortization

34218

usd

CY2023Q4

us-gaap

Deferred Tax Assets Deferred Income

DeferredTaxAssetsDeferredIncome

642948

usd

CY2023Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

135019

usd

CY2022Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense

DeferredTaxAssetsTaxDeferredExpense

427659

usd

CY2022Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

89808

usd

CY2023Q4

FDCT

Deferred Tax Assets Prior Year Nol

DeferredTaxAssetsPriorYearNOL

-1395876

usd

CY2023Q4

FDCT

Deferred Tax Liabilities Prior Year Nol

DeferredTaxLiabilitiesPriorYearNOL

-293134

usd

CY2022Q4

FDCT

Deferred Tax Assets Prior Year Nol

DeferredTaxAssetsPriorYearNOL

-968217

usd

CY2022Q4

FDCT

Deferred Tax Liabilities Prior Year Nol

DeferredTaxLiabilitiesPriorYearNOL

-203325

usd

CY2023Q4

FDCT

Deferred Tax Assets Cumulative Nol

DeferredTaxAssetsCumulativeNOL

-752928

usd

CY2023Q4

FDCT

Deferred Tax Liabilities Cumulative Nol

DeferredTaxLiabilitiesCumulativeNOL

-158115

usd

Concept	2024 Q4	2023 Q4	2023
Revenue			$12.75M
YoY Change			97.64%
Cost Of Revenue			$6.507M
YoY Change			19.73%
Gross Profit			$6.248M
YoY Change			513.17%
Gross Profit Margin			48.98%
Selling, General & Admin			$4.457M
YoY Change			116.14%
% of Gross Profit			71.33%
Research & Development			$0.00
YoY Change			-100.0%
% of Gross Profit			0.0%
Depreciation & Amortization			$213.9K
YoY Change			34.49%
% of Gross Profit			3.42%
Operating Expenses			$4.671M
YoY Change			126.51%
Operating Profit			$1.577M
YoY Change			-251.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net			-$9.418K
YoY Change			-84.64%
Pretax Income			$1.568M
YoY Change			-241.97%
Income Tax
% Of Pretax Income
Net Earnings			$1.573M
YoY Change			-242.63%
Net Earnings / Revenue			12.33%
Basic Earnings Per Share
Diluted Earnings Per Share			$0.00
COMMON SHARES
Basic Shares Outstanding	388.6M shares	333.6M shares	329.5M shares
Diluted Shares Outstanding			329.5M shares

Concept	2024 Q4	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$31.32M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses		$403.2K
Receivables		$1.029M
Other Receivables
Total Short-Term Assets		$40.95M
YoY Change		4886.28%
LONG-TERM ASSETS
Property, Plant & Equipment		$163.6K
YoY Change		-93.82%
Goodwill
YoY Change
Intangibles		$1.305M
YoY Change		-50.67%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$6.594M
YoY Change		91.35%
TOTAL ASSETS
Total Short-Term Assets		$40.95M
Total Long-Term Assets		$6.594M
Total Assets		$47.54M
YoY Change		1014.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$180.0K
YoY Change		-58.1%
Accrued Expenses		$534.5K
YoY Change		160.95%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$33.49M
YoY Change		2342.0%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$33.49M
Total Long-Term Liabilities
Total Liabilities		$34.49M
YoY Change		2173.45%
SHAREHOLDERS EQUITY
Retained Earnings		-$2.644M
YoY Change		-39.02%
Common Stock		$38.86K
YoY Change		83.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$13.01M
YoY Change
Total Liabilities & Shareholders Equity		$47.54M
YoY Change		1014.06%

Concept	2024 Q4	2023 Q4	2023
OPERATING ACTIVITIES
Net Income			$1.573M
YoY Change			-242.63%
Depreciation, Depletion And Amortization			$213.9K
YoY Change			34.49%
Cash From Operating Activities			$20.98M
YoY Change			-4581.78%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			$1.165M
YoY Change			-531.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.050M
YoY Change			1360.7%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$8.906M
YoY Change			879.51%
NET CHANGE
Cash From Operating Activities			$20.98M
Cash From Investing Activities			$1.165M
Cash From Financing Activities			$8.906M
Net Change In Cash			$31.05M
YoY Change			18028.85%
FREE CASH FLOW
Cash From Operating Activities			$20.98M
Capital Expenditures
Free Cash Flow
YoY Change

Name	View Source	Status
0001493152-24-041145-index-headers.html	Edgar Link	pending
0001493152-24-041145-index.html	Edgar Link	pending
0001493152-24-041145.txt	Edgar Link	pending
0001493152-24-041145-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
fdct-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
fdct-20231231_cal.xml	Edgar Link	unprocessable
fdct-20231231_def.xml	Edgar Link	unprocessable
fdct-20231231_lab.xml	Edgar Link	unprocessable
fdct-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FDCT
FDCTECH, INC. Stock $fdct

2024 Q4 Form 10-K Financial Statement

#000149315224041145 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FDCT FDCTECH, INC. Stock $fdct

2024 Q4 Form 10-K Financial Statement

#000149315224041145 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FDCT
FDCTECH, INC. Stock $fdct